Joan Choo, Abraham Jing-Ching Wu, Steven Brad Maron, Smita Suhas Joshi, David Herman Ilson, Yelena Y. Janjigian, Marina Shcherba, Jia Li, Laura H. Tang, Smita Sihag, Bernard J. Park, David R. Jones, Daniela Molena, Geoffrey Yuyat Ku. "Survival outcomes for phase II study of durvalumab (D) and tremelimumab (T) plus PET-directed chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma (EA).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.397